Lowering of plasma phospholipid transfer protein activity by acute hyperglycaemia-induced hyperinsulinaemia in healthy men

References

• Durrington P N. Hyperlipidemia. Diagnosis and Management2nd ed. Butterworth Hein-emann, Oxford 1995
   Google Scholar
• Eisenberg S. High density lipoprotein metabolism. J Lipid Res 1984; 25: 1017–58
   PubMed Web of Science ®Google Scholar
• Dullaart R PF, Groener J EM, Erkelens D W. Cholesterylester transfer between lipoproteins. Diab Nutr Metab 1991; 4: 329–43
   Google Scholar
• Tall A R. Plasma cholesteryl ester transfer protein. J Lipid Res 1993; 34: 1255–74
   PubMed Web of Science ®Google Scholar
• Lagrost L. Regulation of cholesteryl ester transfer protein (CETP) activity: review of in vitro and in vivo studies. Biochim Biophys Acta 1994; 1215: 209–36
   PubMed Web of Science ®Google Scholar
• Tall A R, Krumholz S, Olivecrona T, Deckelbaum R J. Plasma phospholipid transfer protein enhances transfer and exchange of phos-pholipids between very low density lipoproteins and high density lipoprotein during lipolysis. J Lipid Res 1985; 26: 842–51
   PubMed Web of Science ®Google Scholar
• Tollefson J H, Ravnik S, Albers J J. Isolation and characterization of a phospholipid transfer protein (LTP II) from human plasma. J Lipid Res 1988; 29: 1593–1602
   PubMed Web of Science ®Google Scholar
• Speijer H, Groener J E, van Ramshorst E, Van Tol A. Different locations of cholesteryl ester transfer protein and phospholipid transfer protein activities in plasma. Atherosclerosis 1991; 90: 159–68
   PubMed Web of Science ®Google Scholar
• Albers J J, Wolfbauer G, Chueng M C, Day J R, Ching A FT, Lok S, et al. Functional expression of human and mouse plasma phospholipid transfer protein: effect of recombinant and plasma PLTP on HDL subspecies. Biochim Biophys Acta 1995; 1258: 27–34
   PubMed Web of Science ®Google Scholar
• Jauhiainen M, Metso J, Pahlman R, Blomqvist S, Van Tol A, Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 1993; 268: 4032–36
   PubMed Web of Science ®Google Scholar
• Tu A, Nishida H I, Nishida T. High density lipoprotein conversion mediated by human plasma phospholipid transfer protein. J Biol Chem 1993; 268: 23098–105
   PubMed Web of Science ®Google Scholar
• McPherson R, Mann C J, Tall A R, Hogue M, Martin L, Milne R, et al. Plasma concentrations of cholesteryl ester transfer protein in hyperlipopro-teinemia. Arterioscl Thromb 1991; 11: 797–804
   PubMed Web of Science ®Google Scholar
• Zhao S, Smelt A HM, Van den Maagdenberg A MJM, et al. Plasma lipoprotein profiles of normocholesterolemic homozygotes for Apolipoprotein E2(Arg158XCys) compared. Clin Chem 1994; 40: 1559–66
   PubMed Web of Science ®Google Scholar
• Dullaart R PF, Gansevoort R T, Dikkeschei L D, de Zeeuw D, de Jong P E, Van Tol A. Role of elevated lecithin: cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients. Kidney Int 1993; 44: 91–7
   PubMed Web of Science ®Google Scholar
• Dullaart R PF, Groener J E, Dikkeschei L D, Erkelens D W, Doorenbos H. Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus-its relationship with serum lipids. Diabetologia 1989; 32: 14–9
   PubMed Web of Science ®Google Scholar
• Dullaart R PF, Sluiter W J, Dikkeschei L D, Hoogenberg K, Van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994; 24: 188–94
   PubMed Web of Science ®Google Scholar
• Arai T, Yamashita S, Hirano K, et al. Increased plasma cholesteryl ester transfer protein in obese subjects. Arterioscler Thromb 1994; 14: 1129–36
   PubMed Web of Science ®Google Scholar
• Dullaart R PF, Hoogenberg K, Dikkeschei L D, Van Tol A. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioscler Thromb 1994; 14: 1581–5
   PubMed Web of Science ®Google Scholar
• Yki-Jarvinen H, Taskinen M R, Nikkila E A. Response of adipose tissue lipoprotein lipase activity and serum lipoproteins to acute hyperin-sulinaemia in man. Diabetologia 1984; 27: 364–9
   PubMed Web of Science ®Google Scholar
• Lewis G F, Uffelman K D, Szeto L W, Steiner G. Effects of acute hyperinsulinaemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 1993; 42: 833–42
   PubMed Web of Science ®Google Scholar
• Arrol S, Mackness M I, Laing I, Durrington P N. Effects of insulin and glucagon on the secretion of apolipoprotein B-containing lipoproteins and triacylglycerol synthesis by human hepatoma (Hep G2) cells. Diab Nutr Metab 1994; 7: 263–71
   Google Scholar
• Lewis G F, Uffelman K D, Szeto A W, Weller B, Steiner G. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 1995; 95: 158–66
   PubMed Web of Science ®Google Scholar
• Sutherland W HF, Walker R J, Lewis-Barned N J, Pratt H, Tilhnan H C. The effect of acute hyper-insulinemia on plasma cholesteryl ester transfer protein activity in patients with non-insulin-dependent diabetes mellitus and healthy subjects. Metabolism 1994; 43: 1362–6
   PubMed Web of Science ®Google Scholar
• DeFronzo R A, Tobin J D, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214–23
   PubMed Web of Science ®Google Scholar
• Van Haeften T W, Boonstra E, Veneman T F, Gerich J E, Van der Veen E A. Dose-response characteristics for glucose-stimulated insulin release in man and the assessment of influence of glucose on arginine stimulated insulin release. Metabolism 1990; 39: 1292–9
   PubMed Web of Science ®Google Scholar
• Mitrakou A, Vuorinen-Markkoia H, Raptis G, et al. Simultaneous assessment of insulin secretion and insulin sensitivity using a hyperglycemic clamp. J Clin Endocrinol Metab 1992; 75: 379–82
   PubMed Web of Science ®Google Scholar
• Groener J E, Pelton R W, Kostner G M. Improved estimation of cholesteryl ester transfer/exchange activity in serum or plasma. Clin Chem 1986; 32: 283–86
   PubMed Web of Science ®Google Scholar
• Hannuksela M, Marcel Y L, Kesaniemi Y A, Savolainen M J. Reduction in the concentration and activity of plasma cholesteryl ester transfer protein by alcohol. J Lipid Res 1992; 33: 737–44
   PubMed Web of Science ®Google Scholar
• Groener J EM, Da Col P G, Kostner G M. A hyperalphalipoproteinemic family with normal cholesteryl ester transfer/exchange activity. Bio-chem J 1987; 242: 27–32
   PubMed Web of Science ®Google Scholar
• Laakso M, Sarlund H, Mykkanen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arterioscler Thromb 1990; 10: 223–31
   Web of Science ®Google Scholar
• DeFronzo R A, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173–94
   PubMed Web of Science ®Google Scholar
• Facchini F S, Hollenbeck C B, Jeppesen J, Chen Y D, Reaven G M. Insulin resistance and cigarette smoking. Lancet 1992; 339: 1128–30
   PubMed Web of Science ®Google Scholar
• Elcheby M, Pulcini T, Porokhov B, Berthezene F, Ponsin G. Multiple abnormalities in the transfer of phospholipids from VLDL and LDL to HDL in non-insulin-dependent diabetes. Eur J Clin Invest 1996; 26: 216–23
   PubMed Web of Science ®Google Scholar
• Reaven G M, Laws A. Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease. Diabetologia 1994; 37: 948–52
   PubMed Web of Science ®Google Scholar
• Lusa S, Jauhiainen M, Metso J, Somerharju P, Ehnholm C. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Biochem J 1996; 313: 275–82
   PubMed Web of Science ®Google Scholar
• Fielding C J, Fielding P E. Molecular physiology of reverse cholesterol transport ‘review’. J Lipid Res 1995; 36: 211–28
   PubMed Web of Science ®Google Scholar
• Von Eckardstein A, Jauhiainen M, Huang Y, et al. Phospholipid transfer protein mediated conversion of high density lipoproteins generates preβ-HDL. Biochim Biophys Acta 1996; 1301: 255–262
   PubMed Web of Science ®Google Scholar
• Jiang X-C, Bruce C. Regulation of murine plasma phospholipid transfer protein activity and mRNA levels by lipopolysaccharide and high cholesterol diet. J Biol Chem 1995; 270: 17133–8
   PubMed Web of Science ®Google Scholar
• Lagrost L, Florentin E, Guyard-Dangremont V, Athias A, Gandjini H, Lallemant C, et al. Evidence for nonesterified fatty acids as modulators of neutral lipid transfers in normolipidemic human plasma. Arterioscler Thromb Vase Biol 1995; 15: 1388–96
   PubMed Web of Science ®Google Scholar
• Barter P J, Chang L BF, Rajaram O V. Sodium oleate promotes a redistribution of cholesteryl esters from high to low density lipoproteins. Atherosclerosis 1990; 84: 13–24
   PubMed Web of Science ®Google Scholar
• Lagrost L, Barter P J. Effects of various nonesterified fatty acids on the transfer of cholesteryl esters from HDL to LDL induced by the cholesteryl ester transfer protein. Biochim Biophys Acta 1991; 1085: 209–216
   PubMed Web of Science ®Google Scholar
• Barter P J, Chang L BF, Newham H H, Rye K-A, Rajaram O V. The interaction of cholesteryl ester transfer and unesterified fatty acids promotes a reduction in the particle size of high-density lipoproteins. Biochim Biophys Acta 1990; 1045: 81–89
   PubMed Web of Science ®Google Scholar
• Austin M A. Plasma triglycerides as a risk factor for coronary heart disease: epidemiologic evidence and beyond. Amer J Epidemiol 1989; 129: 249–59
   PubMed Web of Science ®Google Scholar
• Mann C J, Yen F T, Grant A M, Bihain B E. Mechanism of plasma cholesteryl ester transfer in hyper-triglyceridemia. J Clin Invest 1991; 88: 2059–66
   PubMed Web of Science ®Google Scholar